Current Heart Failure Reports

, Volume 9, Issue 3, pp 228–235 | Cite as

Management of Acute Right Ventricular Failure in the Intensive Care Unit

  • Eric M. GreenEmail author
  • Michael M. Givertz
Decompensated Heart Failure (MM Givertz, Section editor)


Acute failure of the right ventricle is a common challenge in the intensive care unit that is associated with significant morbidity and mortality. Although often a complication of left ventricular failure, right ventricular failure is a distinct clinical entity, both in terms of its hemodynamic abnormalities and response to treatment. Effective management of right ventricular failure must consider the unique properties of the right ventricle and the pulmonary circulation, and their response to common pharmacologic and mechanical interventions. In this review, we present a contemporary approach to patients with acute failure of the right ventricle including strategies for mechanical ventilation, hemodynamic management, and mechanical circulatory support.


Right ventricle Heart failure Pulmonary hypertension Critical care 



No potential conflicts of interest relevant to this article were reported.


  1. 1.
    Kagan A. Dynamic responses of the right ventricle following extensive damage by cauterization. Circulation. 1952;5(6):816–23.PubMedCrossRefGoogle Scholar
  2. 2.
    Mehta SR, Eikelboom JW, Natarajan MK, Diaz R, Yi C, Gibbons RJ, et al. Impact of right ventricular involvement on mortality and morbidity in patients with inferior myocardial infarction. J Am Coll Cardiol. 2001;37(1):37–43.PubMedCrossRefGoogle Scholar
  3. 3.
    Goldstein JA, Harada A, Yagi Y, Barzilai B, Cox JL. Hemodynamic importance of systolic ventricular interaction, augmented right atrial contractility and atrioventricular synchrony in acute right ventricular dysfunction. J Am Coll Cardiol. 1990;16(1):181–9.PubMedCrossRefGoogle Scholar
  4. 4.
    ••Maeder MT, Holst DP, Kaye DM. Tricuspid regurgitation contributes to renal dysfunction in patients with heart failure. J Card Fail. 2008;14(10):824–30. Elsevier. Renal dysfunction is a frequent complication of heart failure and is thought to result from decreased renal perfusion and low cardiac output. This paper suggests a role for right ventricular failure and venous congestion, specifically tricuspid regurgitation, in renal dysfunction.PubMedCrossRefGoogle Scholar
  5. 5.
    Stein PD, Sabbah HN, Anbe DT, Marzilli M. Performance of the failing and nonfailing right ventricle of patients with pulmonary hypertension. Am J Cardiol. 1979;44(6):1050–5.PubMedCrossRefGoogle Scholar
  6. 6.
    McIntyre KM, Sasahara AA. The hemodynamic response to pulmonary embolism in patients without prior cardiopulmonary disease. Am J Cardiol. 1971;28(3):288–94.PubMedCrossRefGoogle Scholar
  7. 7.
    O’Rourke RA, Dell’Italia LJ. Diagnosis and management of right ventricular myocardial infarction. Curr Probl Cardiol. 2004;29(1):6–47.PubMedCrossRefGoogle Scholar
  8. 8.
    Lahm T, McCaslin CA, Wozniak TC, Ghumman W, Fadl YY, Obeidat OS, et al. Medical and surgical treatment of acute right ventricular failure. J Am Coll Cardiol. 2010;56(18):1435–46.PubMedCrossRefGoogle Scholar
  9. 9.
    Haddad F, Hunt SA, Rosenthal DN, Murphy DJ. Right ventricular function in cardiovascular disease, part I: anatomy, physiology, aging, and functional assessment of the right ventricle. Circulation. 2008;117(11):1436–48.PubMedCrossRefGoogle Scholar
  10. 10.
    Balanos GM, Talbot NP, Dorrington KL, Robbins PA. Human pulmonary vascular response to 4 h of hypercapnia and hypocapnia measured using Doppler echocardiography. J Appl Physiol. 2003;94(4):1543–51.PubMedGoogle Scholar
  11. 11.
    Vieillard-Baron A, Jardin F. Why protect the right ventricle in patients with acute respiratory distress syndrome? Curr Opin Crit Care. 2003;9(1):15–21.PubMedCrossRefGoogle Scholar
  12. 12.
    Jardin F, Vieillard-Baron A. Right ventricular function and positive pressure ventilation in clinical practice: from hemodynamic subsets to respirator settings. Intensive Care Med. 2003;29(9):1426–34.PubMedCrossRefGoogle Scholar
  13. 13.
    David M, von Bardeleben RS, Weiler N, Markstaller K, Scholz A, Karmrodt J, et al. Cardiac function and haemodynamics during transition to high-frequency oscillatory ventilation. Eur J Anaesthesiol. 2004;21(12):944–52.PubMedGoogle Scholar
  14. 14.
    Vieillard-Baron A, Charron C, Caille V, Belliard G, Page B, Jardin F. Prone positioning unloads the right ventricle in severe ARDS. Chest. 2007;132(5):1440–6.PubMedCrossRefGoogle Scholar
  15. 15.
    Sarnoff SJ. Myocardial contractility as described by ventricular function curves; observations on Starling’s law of the heart. Physiol Rev. 1955;35(1):107–22.PubMedGoogle Scholar
  16. 16.
    Cohn JN, Guiha NH, Broder MI, Limas CJ. Right ventricular infarction. Clinical and hemodynamic features. Am J Cardiol. 1974;33(2):209–14.PubMedCrossRefGoogle Scholar
  17. 17.
    Schneider A, Teule G, Groeneveld A. - American Heart Journal - Biventricular performance during volume loading in patients with early septic shock, with emphasis on the right ventricle: a combined hemodynamic and radionuclide study. Am Heart J. 1988;116(1):103–12.PubMedCrossRefGoogle Scholar
  18. 18.
    Piazza G, Goldhaber SZ. The acutely decompensated right ventricle: pathways for diagnosis and management. Chest. 2005;128(3):1836–52.PubMedCrossRefGoogle Scholar
  19. 19.
    Ferrario M, Poli A, Previtali M, Lanzarini L, Fetiveau R, Diotallevi P, et al. Hemodynamics of volume loading compared with dobutamine in severe right ventricular infarction. Am J Cardiol. 1994;74(4):329–33.PubMedCrossRefGoogle Scholar
  20. 20.
    Dell’Italia LJ, Starling MR, Blumhardt R, Lasher JC, O’Rourke RA. Comparative effects of volume loading, dobutamine, and nitroprusside in patients with predominant right ventricular infarction. Circulation. 1985;72(6):1327–35.PubMedCrossRefGoogle Scholar
  21. 21.
    Kerbaul F, Rondelet B, Motte S, Fesler P, Hubloue I, Ewalenko P, et al. Effects of norepinephrine and dobutamine on pressure load-induced right ventricular failure. Crit Care Med. 2004;32(4):1035–40.PubMedCrossRefGoogle Scholar
  22. 22.
    Chen M, Edward P, Bittner M, Hartmuth B, Davis RD, Van Trigt III P. Milrinone improves pulmonary hemodynamics and right ventricular function in chronic pulmonary hypertension. Ann Thorac Surg. 1997;63(3):814–21. Elsevier.PubMedCrossRefGoogle Scholar
  23. 23.
    Levy JH, Bailey JM, Deeb GM. Intravenous milrinone in cardiac surgery. Ann Thorac Surg. 2002;73(1):325–30.PubMedCrossRefGoogle Scholar
  24. 24.
    Tayama E, Ueda T, Shojima T, Akasu K, Oda T, Fukunaga S, et al. Arginine vasopressin is an ideal drug after cardiac surgery for the management of low systemic vascular resistant hypotension concomitant with pulmonary hypertension. Interact Cardiovasc Thorac Surg. 2007;6(6):715–9. Oxford University Press.PubMedCrossRefGoogle Scholar
  25. 25.
    Russ RD, Walker BR. Role of nitric oxide in vasopressinergic pulmonary vasodilatation. Am J Physiol. 1992;262(3 Pt 2):H743–7.PubMedGoogle Scholar
  26. 26.
    Eichinger MR, Walker BR. Enhanced pulmonary arterial dilation to arginine vasopressin in chronically hypoxic rats. Am J Physiol. 1994;267(6 Pt 2):H2413–9.PubMedGoogle Scholar
  27. 27.
    Kwak YL, Lee CS, Park YH, Hong YW. The effect of phenylephrine and norepinephrine in patients with chronic pulmonary hypertension. Anaesthesia. 2002;57(1):9–14.PubMedCrossRefGoogle Scholar
  28. 28.
    Ghignone M, Girling L, Prewitt RM. Volume expansion versus norepinephrine in treatment of a low cardiac output complicating an acute increase in right ventricular afterload in dogs. Anesthesiology. 1984;60(2):132–5.PubMedCrossRefGoogle Scholar
  29. 29.
    Angle MR, Molloy DW, Penner B, Jones D, Prewitt RM. The cardiopulmonary and renal hemodynamic effects of norepinephrine in canine pulmonary embolism. Chest. 1989;95(6):1333–7.PubMedCrossRefGoogle Scholar
  30. 30.
    Le Tulzo Y, Seguin P, Gacouin A, Camus C, Suprin E, Jouannic I, et al. Effects of epinephrine on right ventricular function in patients with severe septic shock and right ventricular failure: a preliminary descriptive study. Intensive Care Med. 1997;23(6):664–70.PubMedCrossRefGoogle Scholar
  31. 31.
    Meldrum DR, Shames BD, Meng X, Fullerton DA, McIntyre RC, Grover FL, et al. Nitric oxide downregulates lung macrophage inflammatory cytokine production. Ann Thorac Surg. 1998;66(2):313–7.PubMedCrossRefGoogle Scholar
  32. 32.
    Inglessis I, Shin JT, Lepore JJ, Palacios IF, Zapol WM, Bloch KD, et al. Hemodynamic effects of inhaled nitric oxide in right ventricular myocardial infarction and cardiogenic shock. J Am Coll Cardiol. 2004;44(4):793–8.PubMedCrossRefGoogle Scholar
  33. 33.
    Ardehali A, Hughes K, Sadeghi A, Esmailian F, Marelli D, Moriguchi J, et al. Inhaled nitric oxide for pulmonary hypertension after heart transplantation. Transplantation. 2001;72(4):638–41.PubMedCrossRefGoogle Scholar
  34. 34.
    Bradford KK, Deb B, Pearl RG. Combination therapy with inhaled nitric oxide and intravenous dobutamine during pulmonary hypertension in the rabbit. J Cardiovasc Pharmacol. 2000;36(2):146.PubMedCrossRefGoogle Scholar
  35. 35.
    Vizza CD, Rocca GD, Roma AD, Iacoboni C, Pierconti F, Venuta F, et al. Acute hemodynamic effects of inhaled nitric oxide, dobutamine and a combination of the two in patients with mild to moderate secondary pulmonary hypertension. Crit Care. 2001;5(6):355–61.PubMedCrossRefGoogle Scholar
  36. 36.
    Khazin V, Kaufman Y, Zabeeda D, Medalion B, Sasson L, Schachner A, et al. Milrinone and nitric oxide: combined effect on pulmonary artery pressures after cardiopulmonary bypass in children. J Cardiothorac Vasc Anesth. 2004;18(2):156–9.PubMedCrossRefGoogle Scholar
  37. 37.
    Christenson J, Lavoie A, O’Connor M, Bhorade S, Pohlman A, Hall JB. The incidence and pathogenesis of cardiopulmonary deterioration after abrupt withdrawal of inhaled nitric oxide. Am J Respir Crit Care Med. 2000;161(5):1443–9.PubMedGoogle Scholar
  38. 38.
    Loh E, Stamler JS, Hare JM, Loscalzo J, Colucci WS. Cardiovascular effects of inhaled nitric oxide in patients with left ventricular dysfunction. Circulation. 1994;90(6):2780–5. Am Heart Assoc.PubMedCrossRefGoogle Scholar
  39. 39.
    Semigran MJ, Cockrill BA, Kacmarek R, Thompson BT, Zapol WM, Dec GW, et al. Hemodynamic effects of inhaled nitric oxide in heart failure. J Am Coll Cardiol. 1994;24(4):982–8. Elsevier.PubMedCrossRefGoogle Scholar
  40. 40.
    Khan TA, Schnickel G, Ross D, Bastani S, Laks H, Esmailian F, et al. A prospective, randomized, crossover pilot study of inhaled nitric oxide versus inhaled prostacyclin in heart transplant and lung transplant recipients. J Thorac Cardiovasc Surg. 2009;138(6):1417–24.PubMedCrossRefGoogle Scholar
  41. 41.
    Gordon C, Collard CD, Pan W. Intraoperative management of pulmonary hypertension and associated right heart failure. Curr Opin Anaesthesiol. 2010;23(1):49–56.PubMedCrossRefGoogle Scholar
  42. 42.
    Sastry BKS, Narasimhan C, Reddy NK, Raju BS. Clinical efficacy of sildenafil in primary pulmonary hypertension: a randomized, placebo-controlled, double-blind, crossover study. J Am Coll Cardiol. 2004;43(7):1149–53.PubMedCrossRefGoogle Scholar
  43. 43.
    Trachte AL, Lobato EB, Urdaneta F, Hess PJ, Klodell CT, Martin TD, et al. Oral sildenafil reduces pulmonary hypertension after cardiac surgery. Ann Thorac Surg. 2005;79(1):194–7. discussion194–7.PubMedCrossRefGoogle Scholar
  44. 44.
    ••Tedford RJ, Hemnes AR, Russell SD, Wittstein IS, Mahmud M, Zaiman AL, et al. PDE5A inhibitor treatment of persistent pulmonary hypertension after mechanical circulatory support. Circ Heart Fail. 2008;1(4):213–9. Persistent pulmonary hypertension and right ventricular dysfunction are risk factors for mortality in end-stage heart failure patients after institution of mechanical circulatory support. This paper suggests that PDE5 inhibitors may improve residual pulmonary hypertension and cardiac output after LVAD implantation.PubMedCrossRefGoogle Scholar
  45. 45.
    Lewis GD, Shah R, Shahzad K, Camuso JM, Pappagianopoulos PP, Hung J, et al. Sildenafil improves exercise capacity and quality of life in patients with systolic heart failure and secondary pulmonary hypertension. Circulation. 2007;116:1555–62.Google Scholar
  46. 46.
    Nagendran J, Archer SL, Soliman D, Gurtu V, Moudgil R, Haromy A, et al. Phosphodiesterase Type 5 is highly expressed in the hypertrophied human right ventricle, and acute inhibition of phosphodiesterase Type 5 improves contractility. Circulation. 2007;116:238–48.PubMedCrossRefGoogle Scholar
  47. 47.
    Love JC, Haffajee CI, Gore JM, Alpert JS. Reversibility of hypotension and shock by atrial or atrioventricular sequential pacing in patients with right ventricular infarction. Am Heart J. 1984;108(1):5–13.PubMedCrossRefGoogle Scholar
  48. 48.
    Topol EJ, Goldschlager N, Ports TA, Dicarlo LA, Schiller NB, Botvinick EH, et al. Hemodynamic benefit of atrial pacing in right ventricular myocardial infarction. Ann Intern Med. 1982;96(5):594–7.PubMedGoogle Scholar
  49. 49.
    Dubin AM, Feinstein JA, Reddy VM, Hanley FL, Van Hare GF, Rosenthal DN. Electrical resynchronization: a novel therapy for the failing right ventricle. Circulation. 2003;107(18):2287–9.PubMedCrossRefGoogle Scholar
  50. 50.
    Kahn D. Postinfarct refractory right ventricle: right ventricular exclusion. A possible option to mechanical cardiac support, in patients unsuitable for heart transplant. J Cardiovasc Surg. 2000;41(3):349–55.Google Scholar
  51. 51.
    Hangler HB, Bonatti JO, Antretter H, Mair P, Müller LC. Isolated right ventricular assist for postcardiotomy myocardial infarction. Ann Thorac Surg. 1999;68(6):2326–8.PubMedCrossRefGoogle Scholar
  52. 52.
    Moazami N, Pasque MK, Moon MR, Herren RL, Bailey MS, Lawton JS, et al. Mechanical support for isolated right ventricular failure in patients after cardiotomy. J Heart Lung Transplant. 2004;23(12):1371–5. Elsevier.PubMedCrossRefGoogle Scholar
  53. 53.
    Furukawa K, Motomura T, Nosé Y. Right ventricular failure after left ventricular assist device implantation: the need for an implantable right ventricular assist device. Artif Organs. 2005;29(5):369–77. Wiley Online Library.PubMedCrossRefGoogle Scholar
  54. 54.
    Klima U, Ringes-Lichtenberg S, Warnecke G, Lichtenberg A, Struber M, Haverich A. Severe right heart failure after heart transplantation. A single-center experience. Transplant Int. 2005;18(3):326–32.CrossRefGoogle Scholar
  55. 55.
    Berman M, Tsui S, Vuylsteke A, Klein A, Jenkins DP. Life-threatening right ventricular failure in pulmonary hypertension: RVAD or ECMO? J Heart Lung Transplant. 2008;27(10):1188–9.PubMedCrossRefGoogle Scholar
  56. 56.
    ••Berman M, Tsui S, Vuylsteke A, Snell A, Colah S, Latimer R, et al. Successful extracorporeal membrane oxygenation support after pulmonary thromboendarterectomy. Ann Thorac Surg. 2008;86(4):1261–7. Patients with persistent pulmonary hypertension following pulmonary thromboendarterectomy have a high rate of mortality. This paper reports the successful use of VA-ECMO for complete cardiorespiratory support in aiding their recovery.PubMedCrossRefGoogle Scholar
  57. 57.
    Conrad SA, Rycus PT, Dalton H. Extracorporeal life support registry report 2004. ASAIO J. 2005;51(1):4–10.PubMedCrossRefGoogle Scholar
  58. 58.
    Rozkovec A, Montanes P, Oakley CM. Factors that influence the outcome of primary pulmonary hypertension. Heart. 1986;55(5):449–58.CrossRefGoogle Scholar
  59. 59.
    Hopkins WE, Ochoa LL, Richardson GW, Trulock EP. Comparison of the hemodynamics and survival of adults with severe primary pulmonary hypertension or Eisenmenger syndrome. J Heart Lung Transplant. 1996;15(1 Pt 1):100–5.PubMedGoogle Scholar
  60. 60.
    Sandoval J, Gaspar J, Pulido T, Bautista E, Martínez-Guerra ML, Zeballos M, et al. Graded balloon dilation atrial septostomy in severe primary pulmonary hypertension. A therapeutic alternative for patients nonresponsive to vasodilator treatment. J Am Coll Cardiol. 1998;32(2):297–304.PubMedCrossRefGoogle Scholar
  61. 61.
    Rich S, Dodin E, McLaughlin VV. Usefulness of atrial septostomy as a treatment for primary pulmonary hypertension and guidelines for its application. Am J Cardiol. 1997;80(3):369–71.PubMedCrossRefGoogle Scholar
  62. 62.
    Blanc J, Vouhé P, Bonnet D. Potts shunt in patients with pulmonary hypertension. N Engl J Med. 2004;350(6):623–3. Mass Medical Soc.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2012

Authors and Affiliations

  1. 1.Cardiovascular DivisionBrigham and Women’s HospitalBostonUSA

Personalised recommendations